微小组织相容性抗原HA-1在慢性髓性白血病患者中由移植物抗宿主驱动的移植物抗白血病效应 - Suppr

Suppr

超能文献

Graft-versus-host driven graft-versus-leukemia effect of minor histocompatibility antigen HA-1 in chronic myeloid leukemia patients.

作者信息

Mutis T, Brand R, Gallardo D, van Biezen A, Niederwieser D, Goulmy E

出版信息

Leukemia. 2010 Jul;24(7):1388-92. doi: 10.1038/leu.2010.115. Epub 2010 May 27.

DOI:10.1038/leu.2010.115

PMID:20508613

Abstract

摘要

相似文献

Graft-versus-host driven graft-versus-leukemia effect of minor histocompatibility antigen HA-1 in chronic myeloid leukemia patients.

Leukemia. 2010 Jul;24(7):1388-92. doi: 10.1038/leu.2010.115. Epub 2010 May 27.

[Polymorphic adhesion molecules mediating the graft-versus-leukemia effect].

Rinsho Ketsueki. 2004 Mar;45(3):183-8.

[Role of polymorphic adhesion molecules in the development of graft-versus-leukemia effect after HLA-matched allogeneic stem cell transplantation].

Rinsho Ketsueki. 2004 Jul;45(7):518-23.

Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.

Natl Med J India. 2004 Mar-Apr;17(2):71-3.

Prophylactic impact of imatinib administration after allogeneic stem cell transplantation on the incidence and severity of chronic graft versus host disease in patients with Philadelphia chromosome-positive leukemia.

Leukemia. 2010 Jun;24(6):1236-9. doi: 10.1038/leu.2010.83. Epub 2010 Apr 29.

Individualized intervention guided by BCR-ABL transcript levels after HLA-identical sibling donor transplantation improves HSCT outcomes for patients with chronic myeloid leukemia.

Biol Blood Marrow Transplant. 2011 May;17(5):649-56. doi: 10.1016/j.bbmt.2010.07.023. Epub 2010 Aug 5.

Immunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graft.

Transfusion. 2010 Feb;50(2):418-28. doi: 10.1111/j.1537-2995.2009.02440.x. Epub 2009 Oct 15.

Eradication of residual bcr-abl-positive clones by inducing graft-versus-host disease after allogeneic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Bone Marrow Transplant. 2002 Jan;29(1):63-6. doi: 10.1038/sj.bmt.1703318.

[Donor leukocyte transfusion for relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation].

Rinsho Ketsueki. 2000 Apr;41(4):288-91.

Mismatch of minor histocompatibility antigen contributes to a graft-versus-leukemia effect rather than to acute GVHD, resulting in long-term survival after HLA-identical stem cell transplantation in Japan.

Bone Marrow Transplant. 2006 Nov;38(10):681-6. doi: 10.1038/sj.bmt.1705506. Epub 2006 Sep 18.

引用本文的文献

T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies.

Front Immunol. 2020 Feb 21;11:276. doi: 10.3389/fimmu.2020.00276. eCollection 2020.

Personal tumor antigens in blood malignancies: genomics-directed identification and targeting.

J Clin Invest. 2020 Apr 1;130(4):1595-1607. doi: 10.1172/JCI129209.

Escape from thymic deletion and anti-leukemic effects of T cells specific for hematopoietic cell-restricted antigen.

Nat Commun. 2018 Jan 15;9(1):225. doi: 10.1038/s41467-017-02665-z.

Cell therapies for hematological malignancies: don't forget non-gene-modified t cells!

Blood Rev. 2018 May;32(3):203-224. doi: 10.1016/j.blre.2017.11.004. Epub 2017 Nov 27.

Efficacy of host-dendritic cell vaccinations with or without minor histocompatibility antigen loading, combined with donor lymphocyte infusion in multiple myeloma patients.

Bone Marrow Transplant. 2017 Feb;52(2):228-237. doi: 10.1038/bmt.2016.250. Epub 2016 Nov 14.

Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancers.

Leukemia. 2016 Jun;30(6):1344-54. doi: 10.1038/leu.2016.22. Epub 2016 Feb 9.

Minor histocompatibility Ags: identification strategies, clinical results and translational perspectives.

Bone Marrow Transplant. 2016 Feb;51(2):163-71. doi: 10.1038/bmt.2015.256. Epub 2015 Oct 26.

Possible role of minor h antigens in the persistence of donor chimerism after stem cell transplantation; relevance for sustained leukemia remission.

PLoS One. 2015 Mar 16;10(3):e0119595. doi: 10.1371/journal.pone.0119595. eCollection 2015.

Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1.

Leukemia. 2013 Mar;27(3):642-9. doi: 10.1038/leu.2012.277. Epub 2012 Oct 1.

Association of disparities in known minor histocompatibility antigens with relapse-free survival and graft-versus-host disease after allogeneic stem cell transplantation.

Biol Blood Marrow Transplant. 2013 Feb;19(2):274-82. doi: 10.1016/j.bbmt.2012.09.008. Epub 2012 Sep 27.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验